Parametric Linkage Analysis Identifies Five Novel Genome-Wide Significant Loci for Familial Lung Cancer

Objective: One of four American cancer patients dies of lung cancer. Environmental factors such as tobacco smoking are known to affect lung cancer risk. However, there is a genetic factor to lung cancer risk as well. Here, we perform parametric linkage analysis on family-based genotype data in an effort to find genetic loci linked to the disease. Methods: 197 individuals from families with a high-risk history of lung cancer were recruited and genotyped using an Illumina array. Parametric linkage analyses were performed using an affected-only phenotype model with an autosomal dominant inheritance using a disease allele frequency of 0.01. Three types of analyses were performed: single variant two-point, collapsed haplotype pattern variant two-point, and multipoint analysis. Results: Five novel genome-wide significant loci were identified at 18p11.23, 2p22.2, 14q13.1, 16p13, and 20q13.11. The families most informative for linkage were also determined. Conclusions: The 5 novel signals are good candidate regions, containing genes that have been implicated as having somatic changes in lung cancer or other cancers (though not in germ line cells). Targeted sequencing on the significant loci is planned to determine the causal variants at these loci.

[1]  H. Sakurai,et al.  Inhibition of epithelial–mesenchymal transition by cetuximab via the EGFR‐GEP100‐Arf6‐AMAP1 pathway in head and neck cancer , 2017, Head & neck.

[2]  J. Fujimoto,et al.  Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  J. Herz,et al.  Expression of a recombinant full-length LRP1B receptor in human non-small cell lung cancer cells confirms the postulated growth-suppressing function of this large LDL receptor family member , 2016, Oncotarget.

[4]  S. Powers,et al.  Effectors and potential targets selectively upregulated in human KRAS-mutant lung adenocarcinomas , 2016, Scientific Reports.

[5]  C. Theillet,et al.  TOM1L1 drives membrane delivery of MT1-MMP to promote ERBB2-induced breast cancer cell invasion , 2016, Nature Communications.

[6]  S. Jenks Is Lung Cancer Incidence Increasing in Never-Smokers? , 2016, Journal of the National Cancer Institute.

[7]  W. Han,et al.  Genome Wide Methylome Alterations in Lung Cancer , 2015, PloS one.

[8]  P. Pattyn,et al.  Focus on 16p13.3 Locus in Colon Cancer , 2015, PloS one.

[9]  Hang Dai,et al.  Collapsed haplotype pattern method for linkage analysis of next-generation sequence data , 2015, European Journal of Human Genetics.

[10]  P. Fasching,et al.  The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patients , 2015, Oncotarget.

[11]  Y. Chen,et al.  Identification of lung cancer oncogenes based on the mRNA expression and single nucleotide polymorphism profile data. , 2015, Neoplasma.

[12]  P. Meltzer,et al.  Integrated high-resolution array CGH and SKY analysis of homozygous deletions and other genomic alterations present in malignant mesothelioma cell lines. , 2013, Cancer genetics.

[13]  Hongbing Shen,et al.  Association analyses identify multiple new lung cancer susceptibility loci and their interactions with smoking in the Chinese population , 2012, Nature Genetics.

[14]  Yusuke Nakamura,et al.  A genome-wide association study identifies two new susceptibility loci for lung adenocarcinoma in the Japanese population , 2012, Nature Genetics.

[15]  Kai Wang,et al.  wANNOVAR: annotating genetic variants for personal genomes via the web , 2012, Journal of Medical Genetics.

[16]  Wen Tan,et al.  A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese , 2011, Nature Genetics.

[17]  T. Kiehl,et al.  NPAS3 demonstrates features of a tumor suppressive role in driving the progression of Astrocytomas. , 2011, The American journal of pathology.

[18]  B. Furlow Occupational lung diseases. , 2011, Radiologic technology.

[19]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[20]  Marshall W. Anderson,et al.  A susceptibility locus on chromosome 6q greatly increases lung cancer risk among light and never smokers. , 2010, Cancer research.

[21]  M. Spitz,et al.  Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study. , 2009, Cancer research.

[22]  W. M. Foster,et al.  NPAS3 is a trachealess homolog critical for lung development and homeostasis , 2009, Proceedings of the National Academy of Sciences.

[23]  Y. Onodera,et al.  The EGFR-GEP100-Arf6-AMAP1 Signaling Pathway Specific to Breast Cancer Invasion and Metastasis† , 2009, Traffic.

[24]  Christopher I Amos,et al.  Common 5p15.33 and 6p21.33 variants influence lung cancer risk , 2008, Nature Genetics.

[25]  S. Feller,et al.  Odin (ANKS1A) is a Src family kinase target in colorectal cancer cells , 2008, Cell Communication and Signaling.

[26]  Susann M Brady-Kalnay,et al.  Tumor-Derived Extracellular Mutations of PTPRT/PTPρ Are Defective in Cell Adhesion , 2008, Molecular Cancer Research.

[27]  G. Mills,et al.  Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1 , 2008, Nature Genetics.

[28]  Daniel F. Gudbjartsson,et al.  A variant associated with nicotine dependence, lung cancer and peripheral arterial disease , 2008, Nature.

[29]  Paolo Vineis,et al.  A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25 , 2008, Nature.

[30]  Francisco M De La Vega,et al.  A second-generation combined linkage physical map of the human genome. , 2007, Genome research.

[31]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[32]  S. Kardia,et al.  Risk of lung cancer among white and black relatives of individuals with early-onset lung cancer. , 2005, JAMA.

[33]  T. Manabe,et al.  Expression of AMAP1, an ArfGAP, provides novel targets to inhibit breast cancer invasive activities , 2005, The EMBO journal.

[34]  Marshall W. Anderson,et al.  A major lung cancer susceptibility locus maps to chromosome 6q23-25. , 2004, American journal of human genetics.

[35]  Giovanni Parmigiani,et al.  Mutational Analysis of the Tyrosine Phosphatome in Colorectal Cancers , 2004, Science.

[36]  Douglas Boyd,et al.  Invasion and metastasis , 1996, Cancer and Metastasis Reviews.

[37]  M. Spitz,et al.  Risk for smoking-related cancer among relatives of lung cancer patients. , 2003, Cancer research.

[38]  Michael J Thun,et al.  Lung cancer mortality in relation to age, duration of smoking, and daily cigarette consumption: results from Cancer Prevention Study II. , 2003, Cancer research.

[39]  Yonghe Li,et al.  Low Density Lipoprotein (LDL) Receptor-related Protein 1B Impairs Urokinase Receptor Regeneration on the Cell Surface and Inhibits Cell Migration* , 2002, The Journal of Biological Chemistry.

[40]  Jeanette C Papp,et al.  Detection and integration of genotyping errors in statistical genetics. , 2002, American journal of human genetics.

[41]  G. Abecasis,et al.  Merlin—rapid analysis of dense genetic maps using sparse gene flow trees , 2002, Nature Genetics.

[42]  D E Weeks,et al.  Multipoint Estimation of Identity-by-Descent Probabilities at Arbitrary Positions among Marker Loci on General Pedigrees , 2001, Human Heredity.

[43]  S. Yaklichkin,et al.  Genomic organization of a new candidate tumor suppressor gene, LRP1B. , 2000, Genomics.

[44]  Richard Doll,et al.  Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies , 2000, BMJ : British Medical Journal.

[45]  L Sun,et al.  Statistical tests for detection of misspecified relationships by use of genome-screen data. , 2000, American journal of human genetics.

[46]  K Lange,et al.  Descent graphs in pedigree analysis: applications to haplotyping, location scores, and marker-sharing statistics. , 1996, American journal of human genetics.

[47]  E. Lander,et al.  Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results , 1995, Nature Genetics.

[48]  M H Skolnick,et al.  Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. , 1994, Journal of the National Cancer Institute.

[49]  R. Doll,et al.  Mortality in relation to consumption of alcohol: 13 years' observations on male British doctors , 1994, BMJ.

[50]  R Doll,et al.  Mortality in relation to smoking: 40 years' observations on male British doctors , 1994, BMJ.

[51]  M H Skolnick,et al.  Familiality of cancer in Utah. , 1994, Cancer research.

[52]  D. Carbone Smoking and cancer. , 1992, The American journal of medicine.

[53]  T. Pechacek,et al.  Smoking-attributable cancer mortality in 1991: is lung cancer now the leading cause of death among smokers in the United States? , 1991, Journal of the National Cancer Institute.

[54]  E. Pollack,et al.  What are the odds that smoking will kill you? , 1987, American journal of public health.

[55]  R. Elston,et al.  Increased familial risk for lung cancer. , 1986, Journal of the National Cancer Institute.

[56]  R. Doll,et al.  The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. , 1981, Journal of the National Cancer Institute.

[57]  P. Burch Smoking and lung cancer. Tests of a causal hypothesis. , 1980, Journal of chronic diseases.

[58]  A. Lilienfeld,et al.  Familial aggregation of lung cancer among hospital patients. , 1963, Public health reports.

[59]  A. Lilienfeld,et al.  Familial aggregation of lung cancer in humans. , 1963, Journal of the National Cancer Institute.